Martine Zimmermann sold $636K of LGND stock
By AlphaYouPublished Form 4
Zimmermann Martine
Reporting filer
Martine Zimmermann reported selling 2,000 shares of Ligand Pharmaceuticals Inc for about $636K ($318.17 a share on average). Form 4 filed Nov 16, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Nov 16, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Zimmermann Martine | 2026-11-12 | S | Sale | 2000 | 318.1681 | 1,782 | 4 days | Filed terms
|
Common Stock
- Owner
- Zimmermann Martine
- Date
- 2026-11-12
- Code
- S
- Action
- Sale
- Quantity
- 2000
- Price
- 318.1681
- Following holdings
- 1,782
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-12
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 2000
- transaction Price Per Share: 318.1681
- id: F1
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 1782
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Zimmermann Martine: Director.
- F1: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $318.00 to $318.86. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Original sources
Prepared automatically from public filing data. Report a correction.